Phage Safety Retrospective Cohort Study

Recruiting

Interventions: Other: patients having had avderse event after phagotherapy for bone or joint or implant infection

Brief Summary: The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whether these adverse effects are related to surgery, antibiotic treatment or bacteriophages.

Recruitment & Eligibility

Inclusion Criteria

patients having had a bone or joint or implant infection treated by phagotherapy and having had an adverse event

Exclusion Criteria

Arm && Interventions

Group	Intervention	Description
patients having had avderse event after phagotherapy for bone or joint infection	patients having had avderse event after phagotherapy for bone or joint or implant infection	-

Primary Outcome Measures

Name	Time	Method
rate of patients having had an adverse event	1 year	number of patients having had an adverse event
rate of adverse event attributable to the surgery	1 year	number of patients having had an adverse event because of the surgery
type of adverse event attributable to the surgery	1 year	classification according to Clavien's Clasification
rate of adverse event attributable to the antibiotic treatment	1 year	number of patients having had an adverse event because of the antibiotic treatment
rate of adverse event attributable to the phagotherapy	1 year	number of patients having had an adverse event because of phagotherapy

Secondary Outcome Measures

Name	Time	Method

Receive instant email notifications about changes in this clinical trial

Receive instant email notifications about changes in this clinical trial